NUS researchers discover protein that promotes chemotherapy resistance

(National University of Singapore, Yong Loo Lin School of Medicine) Researchers from NUS Medicine's Immunology Translational Research Programme and NUS Center for Cancer Research (N2CR) have identified how a molecule called DUSP16 plays an important role in a cancer patient's response to chemotherapeutic drugs. The study also found that chemotherapy drugs are a factor in the increased expression of DUSP16. This means that once chemotherapy begins, the expression of DUSP16 will increase in patien...